Pfizer has scored FDA approval for its Prevnar 20 vaccine for adults 18 and older. Pfizer's (NSE:PFE) pneumococcal 13-valent conjugate vaccine prevnar 13 is one of pharma's bestseller earning nearly $6 billion last year. The vaccine…
Novel defense mechanism for SARS-CoV-2 discovered
Scientists from Hokkaido University have discovered a novel defensive response to SARS-CoV-2 that involves the viral pattern recognition receptor RIG-I. Upregulating expression of this protein could strengthen the immune response in COPD patients. In the…
Nonprofits, Government Surpass Pharma in Alzheimer’s Drug Development
Two articles published by Alzheimer's & Dementia: Translational Research & Clinical Interventions show substantial changes in the focus and funding of clinical trials for Alzheimer's disease therapies. The newly published articles throw a greater spotlight on a…
Clinical trial repurposes cancer drug for treatment of vascular malformations
By Natasha Kassulke Beth Drolet, chair of the Department of Dermatology at the University of Wisconsin School of Medicine and Public Health, is motivated by the stories of the pain and disfigurement that some of…
Clean Water and Toilets for Healthy Shelters
The devastating Great East Japan Earthquake on March 11, 2011 displaced some 500,000 people to evacuation shelters. A research team that conducted regular visits to shelters to assess their status and inhabitants well-being have analyzed…